Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2023-03-31 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
信息披露事务管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for information disclosure of a listed company, including comprehensive rules and procedures for disclosure of various types of reports such as annual reports, interim reports, quarterly reports, and temporary reports. It references regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and covers the responsibilities of the board, management, and disclosure officers. The document is a policy or governance document about how the company manages its information disclosure obligations rather than an actual financial report or announcement. It does not contain financial data or results, nor is it an announcement of a report publication. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices related to disclosure.
2023-03-31 Chinese
委托理财管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for entrusted financial management by Tianjin Ruipu Biotechnology Co., Ltd. It outlines internal policies, principles, approval authorities, risk control, and operational procedures related to the company's entrusted financial management activities. There is no indication that this is a financial report, earnings release, or regulatory filing. It is a governance-related document detailing internal rules and procedures for managing entrusted financial products. The document length is 3682 characters, which is relatively short but contains substantive policy content rather than an announcement or certification. Therefore, the most appropriate classification is Governance Information (CGR).
2023-03-31 Chinese
关于续聘会计师事务所的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding the reappointment of an accounting firm (立信会计师事务所) as the auditor for the company for the 2023 fiscal year. It details the qualifications, experience, and independence of the accounting firm and the approval process by the board and independent directors. The document does not contain any financial statements or audit reports themselves but is an announcement about the auditor appointment for the upcoming audit period. The document length is 3481 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this fits best under the category of Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report itself. However, since it is specifically about the appointment of the auditor and not the audit report or results, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is an announcement about audit firm appointment rather than the audit report itself.
2023-03-31 Chinese
独立董事对第五届董事会第三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion report from independent directors regarding various board meeting matters, including appointment of auditors, related party transactions, internal control evaluation, profit distribution, appointment of general manager, remuneration adjustments, and amendments to the company charter. It references compliance with regulatory rules and company bylaws but does not contain financial statements or detailed financial data. The document is a formal opinion on board/management matters rather than a full report or announcement of a report. Therefore, it fits best under Board/Management Information (MANG). The document length is 2762 characters, which is relatively short but contains substantive content related to board decisions and management changes, including appointment of a new general manager and remuneration adjustments.
2023-03-31 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled "天津瑞普生物技术股份有限公司2022 年年度报告全文" which translates to "Tianjin Ringpu Biotechnology Co., Ltd. 2022 Annual Report Full Text." It contains detailed sections including company overview, financial data, management discussion and analysis, governance, environmental and social responsibility, important matters, shareholder information, bond information, and financial statements. The document is lengthy (15,000 characters) and includes comprehensive financial and operational data for the full fiscal year 2022. It also includes auditor information and signed financial statements, which are typical components of an official annual report. There is no indication that this is merely an announcement or a summary; it is the full annual report itself. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-03-31 Chinese
独立董事2022年度述职报告（才学鹏）
Board/Management Information Classification · 95% confidence The document is titled '独立董事2022 年度述职报告' which translates to 'Independent Director 2022 Annual Work Report'. It is a detailed report by an independent director about their duties, attendance at board meetings, opinions on major company matters, committee work, investor protection efforts, and training during the year 2022. The content focuses on the independent director's activities and responsibilities over the year, which aligns with a management or board-related report rather than a full annual financial report or regulatory filing. The document length is 2513 characters, which is relatively short but contains substantive content about management activities and governance. It is not an announcement or certification but a detailed report on the independent director's work. Therefore, the best fitting category is Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities.
2023-03-31 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.